SCHEMBL1614735

SCHEMBL1614735

Cc1nn2c(=O)cc(CNCOCc3ccc(C(F)(F)F)cc3)[nH]c2c1-c1cccs1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAT P00750 2/20 0.33
MYC P01106 1/20 0.32
MAX P61244 1/20 0.32
PDE2A O00408 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
NPC1 O15118 1/20 0.32
MAPT P10636 1/20 0.32
RAB9A P51151 1/20 0.32
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
ALDH1A1 P00352 4/20 0.31
GAA P10253 4/20 0.31
KDM4E B2RXH2 3/20 0.31
HPGD P15428 2/20 0.31
GLA P06280 1/20 0.31
KCNQ3 O43525 1/20 0.31
KCNQ2 O43526 1/20 0.31
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15926318 0.91 MAPK14 (0.32) MYCMAXHCAR2MAPTS1PR1
SCHEMBL1614666 0.90 MAPT (0.33) MYCMAXHCAR2MAPTALDH1A1
SCHEMBL1615018 0.89 HCAR2 (0.35) PLATPDE2AHCAR2SMN1; SMN2NPC1
SCHEMBL15926328 0.89 MAPK14 (0.31) MAPTMAPK14
SCHEMBL1613466 0.87 AR (0.40) PLATPDE2ASMN1; SMN2NPC1MAPT
SCHEMBL15909002 0.84 P2RX7 (0.40) MYCMAXSMN1; SMN2NPC1RAB9A
SCHEMBL1614928 0.83 KCNQ3 (0.36) PLATPDE2AHCAR2KCNQ3KCNQ2
SCHEMBL15926361 0.80 HCAR2 (0.35) HCAR2SMN1; SMN2NPC1MAPTRAB9A
SCHEMBL15926362 0.80 AR (0.37) PLATPDE2AALDH1A1GAAKDM4E
SCHEMBL1613995 0.79 PDE2A (0.34) PLATPDE2ASMN1; SMN2NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof KCNJ2, KCNQ5, KCNJ11 PLAT 1286/4885MYC 2729/4885MAX 3903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.